186 related articles for article (PubMed ID: 18396336)
1. Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression.
LaCasse RA; Striebel JF; Favara C; Kercher L; Chesebro B
J Neuroimmunol; 2008 May; 196(1-2):16-26. PubMed ID: 18396336
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein.
Rangel A; Race B; Phillips K; Striebel J; Kurtz N; Chesebro B
Acta Neuropathol Commun; 2014 Jan; 2():8. PubMed ID: 24447368
[TBL] [Abstract][Full Text] [Related]
3. Complement 3
Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
[TBL] [Abstract][Full Text] [Related]
4. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice.
Repeke CE; Ferreira SB; Claudino M; Silveira EM; de Assis GF; Avila-Campos MJ; Silva JS; Garlet GP
Bone; 2010 Apr; 46(4):1122-30. PubMed ID: 20053385
[TBL] [Abstract][Full Text] [Related]
5. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-1 in prion disease-associated astrocyte activation.
Schultz J; Schwarz A; Neidhold S; Burwinkel M; Riemer C; Simon D; Kopf M; Otto M; Baier M
Am J Pathol; 2004 Aug; 165(2):671-8. PubMed ID: 15277240
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression.
Liu Y; Sorce S; Nuvolone M; Domange J; Aguzzi A
Sci Rep; 2018 Oct; 8(1):14600. PubMed ID: 30279468
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice.
Gray BC; Skipp P; O'Connor VM; Perry VH
Biochem Soc Trans; 2006 Feb; 34(Pt 1):51-4. PubMed ID: 16417481
[TBL] [Abstract][Full Text] [Related]
9. In Situ Temporospatial Characterization of the Glial Response to Prion Infection.
Michael AV; Greenlee JJ; Harm TA; Moore SJ; Zhang M; Lind MS; Greenlee MHW; Smith JD
Vet Pathol; 2020 Jan; 57(1):90-107. PubMed ID: 31331254
[TBL] [Abstract][Full Text] [Related]
10. The expression of RANTES and chemokine receptors in the brains of scrapie-infected mice.
Lee HP; Jun YC; Choi JK; Kim JI; Carp RI; Kim YS
J Neuroimmunol; 2005 Jan; 158(1-2):26-33. PubMed ID: 15589034
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
[TBL] [Abstract][Full Text] [Related]
12. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 confers partial neuroprotection during prion disease.
Carroll JA; Race B; Williams K; Chesebro B
PLoS One; 2018; 13(12):e0208559. PubMed ID: 30596651
[TBL] [Abstract][Full Text] [Related]
14. CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function.
Lee YK; Kwak DH; Oh KW; Nam SY; Lee BJ; Yun YW; Kim YB; Han SB; Hong JT
Neurobiol Learn Mem; 2009 Oct; 92(3):356-63. PubMed ID: 19394434
[TBL] [Abstract][Full Text] [Related]
15. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin is indispensable for activation of astrocytes in injured mouse brain and primary culture.
Ikeshima-Kataoka H; Matsui Y; Uede T
Neurol Res; 2018 Dec; 40(12):1071-1079. PubMed ID: 30246619
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside Synthase Knockout Reduces Prion Disease Incubation Time in Mouse Models.
Kobayashi A; Qi Z; Shimazaki T; Munesue Y; Miyamoto T; Isoda N; Sawa H; Aoshima K; Kimura T; Mohri S; Kitamoto T; Yamashita T; Miyoshi I
Am J Pathol; 2019 Mar; 189(3):677-686. PubMed ID: 30553837
[TBL] [Abstract][Full Text] [Related]
18. ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation.
Thellung S; Villa V; Corsaro A; Pellistri F; Venezia V; Russo C; Aceto A; Robello M; Florio T
Glia; 2007 Nov; 55(14):1469-85. PubMed ID: 17705195
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 expression is correlated with abnormal prion protein accumulation in murine scrapie.
Jin JK; Na YJ; Song JH; Joo HG; Kim S; Kim JI; Choi EK; Carp RI; Kim YS; Shin T
Neurosci Lett; 2007 Jun; 420(2):138-43. PubMed ID: 17531384
[TBL] [Abstract][Full Text] [Related]
20. Abnormally upregulated αB-crystallin was highly coincidental with the astrogliosis in the brains of scrapie-infected hamsters and human patients with prion diseases.
Wang K; Zhang J; Xu Y; Ren K; Xie WL; Yan YE; Zhang BY; Shi Q; Liu Y; Dong XP
J Mol Neurosci; 2013 Nov; 51(3):734-48. PubMed ID: 23832485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
